Tretinoin

维A酸

Report date: 2026/03/16 20:01:47
NME

Base Information

Drug NameTretinoin
Drug Alias Name维甲酸tretinoinum视黄酸all-trans-Retinoic acid维生素A酸 +[19] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionRetinoic acid receptor gamma agonistsRetinoic acid receptor beta agonistsRetinoic acid receptor alpha agonists
TargetsRetinoic acid receptor gammaRetinoic acid receptor betaRetinoic acid receptor alpha
Therapy Area/IndicationsDup15q syndromeSkin InjuriesSolid tumours +[28] 
Global Approved IndicationsPsoriasisAcne VulgarisWarts
Approved Indications in ChinaPsoriasisAcne VulgarisWarts
Original Approved Country/TerritoryUnited States
Original Approved Date1971/10/20
Country/TerritoryUnited StatesThailandNetherlands +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityStanford UniversitySrinakharinwirot University +[10] 
Inactive CompaniesDana-Farber Cancer InstituteWeill Medical College of Cornell UniversityValeant Pharmaceuticals North America Llc +[15] 
Active IndicationsDup15q syndromeSkin InjuriesSolid tumours +[18] 
Inactive IndicationsImmunologic Deficiency SyndromesRosaceaLymphoproliferative Disorders +[10] 

Other Information

ATC CodeD10AD01L01XF01
Related LinksWikipediaDrugBankKEGG